Sciotec Diagnostic Technologies Gmbh

Stada Arzneimittel Ag

Immundiagnostik Ag

Albert Missbichler

Herwig Ernst Reichl

Franz Gabor

Franz Paul Armbruster

Isabella Mayer

Heinrich Schmidt-Gayk

Heinz-Jürgen Roth

Herwig Reichl

The present invention relates to a composition for use in the treatment of an intestinal tract disorder caused by a gluten-associated protein, said composition comprising at least one agent which binds to the gluten-associated protein, characterized in that the composition is administered at the same time as or at most within 60 minutes after administration of at least one tannin to a patient.

Tannin and anti-gliadin antibody compositions for treatment of a disease of the intestinal tract

Method of treating celiac disease

The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.

Diaminooxidase-containing pharmaceutical compositions

The present invention relates to the composition comprising crystalline xylose-isomerase (EC 5.3.1.5) and at least one salt of a metal and/or alkaline earth metal.

Treatment of fructose malabsorption

Disclosed is a method for determining histaminase (DAO; EC 1.4.3.6) activity in a sample. Said method comprises the following steps: an aqueous solution is supplied which contains a predefined amount of a diamine; the aqueous solution is mixed and incubated with the sample for a given period of time in conditions in which the diamine can be reacted with a DAO possibly present in the sample; the diamine is derivatized; the amount of derivatized diamine is determined; the predefined amount of diamine is compared to the amount of derivatized diamine; and the activity of histaminase possibly present is determined.

Method for determining diamine oxidase

Immunoassay for the determination of parathyroid hormone activity in a sample, and for the diagnosis, etiology and treatment of calcium metabolism disturbances, osteopathies and hyper- or hypoparathyroidisms. The parathyroid hormone activity is measured with the aid of an antibody which binds to an epitope in the region of the receptor binding structuretoof the parathyroid hormone, and an antibody which recognizes whether the amino-terminal endtoof the parathyroid hormone is intact. The assay permits the antagonistic characteristics of some parathyroid hormone fragments to be taken into account.

Growing community of inventors

Vienna, Austria

Albert Missbichler